CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage.
about
Wnt3a is critical for endothelial progenitor cell-mediated neural stem cell proliferation and differentiationIlizarov external fixation versus plate internal fixation in the treatment of end-stage ankle arthritis: decision analysis of clinical parameters.CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.CP-25 Attenuates the Activation of CD4+ T Cells Stimulated with Immunoglobulin D in Human.Phytochemicals as modulators of M1-M2 macrophages in inflammation.A Modified Compound From Paeoniflorin, CP-25, Suppressed Immune Responses and Synovium Inflammation in Collagen-Induced Arthritis Mice.
P2860
CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CP-25, a novel compound, prote ...... inflammation and bone damage.
@en
type
label
CP-25, a novel compound, prote ...... inflammation and bone damage.
@en
prefLabel
CP-25, a novel compound, prote ...... inflammation and bone damage.
@en
P2093
P2860
P356
P1433
P1476
CP-25, a novel compound, prote ...... f inflammation and bone damage
@en
P2093
Jingyu Chen
Lingling Zhang
Xiaojing Sun
Xiaoyi Jia
Xuezhi Yang
P2860
P2888
P356
10.1038/SREP26239
P407
P50
P577
2016-05-17T00:00:00Z